A simplified system for generating recombinant E3-deleted canine adenovirus-2

Area of Science:

• Virology
• Molecular Biology
• Biotechnology

Background:

• Canine adenovirus type 2 (CAV-2) is a valuable tool for gene therapy and vaccine development.
• Efficient generation of replication-competent CAV-2 vectors is crucial for these applications.

Purpose of the Study:

• To describe a simple strategy for generating replication-competent recombinant CAV-2.
• To establish a foundation for developing CAV-2-based vaccines and gene therapy vectors.

Main Methods:

• Constructed a full-length CAV-2 genome backbone plasmid via homologous recombination in E. coli.
• Generated a shuttle plasmid with a modified E3 region for gene insertion.
• Utilized unique restriction sites (NruI and SalI) for cloning the expression cassette into the backbone.
• Inserted enhanced green fluorescent protein (EGFP) gene to demonstrate system functionality.

Main Results:

• Successfully generated infectious viral particles containing the EGFP expression cassette.
• Demonstrated the effectiveness of the shuttle vector system for gene insertion.
• Validated the strategy for creating recombinant CAV-2 with desired genetic modifications.

Conclusions:

• The described strategy offers a robust and simple method for producing replication-competent CAV-2.
• This approach facilitates the development of CAV-2 based gene therapy vectors and candidate vaccines.
• The generated recombinant CAV-2 holds potential for future biomedical applications.